Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01207505 · ClinicalTrials.gov registry record · NA
Emotion Regulation Group Therapy for Bipolar Disorder
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01207505: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01207505 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01207505, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Psychoeducation has been the only group treatment developed for bipolar disorder thus far. Deficits in emotion regulation, a core impairment among patients with bipolar disorder, are not directly addressed in this treatment. The objective of this study is to develop a group treatment for bipolar disorder that focuses on emotion regulation strategies (Enhancing Emotion Regulation; EER). This study will examine the efficacy of this treatment using an open trial design. It is hypothesized that patients who receive EER will show a reduction in mood symptoms and improvement in well-being. Reductions in emotion regulation difficulties will predict improvements.
Interventions
- BEHAVIORAL Enhancing Emotion Regulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01207505
The ClinicalTrials.gov registry entry for NCT01207505 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enhancing Emotion Regulation is the first listed.
NCT01207505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01207505 about?
NCT01207505 is a clinical study titled "Emotion Regulation Group Therapy for Bipolar Disorder". Psychoeducation has been the only group treatment developed for bipolar disorder thus far. Deficits in emotion regulation, a core impairment among patients with bipolar disorder, are not directly addressed in this treatment. The objective of this study is to develop a group treatment for bipolar dis...
What is the current status of trial NCT01207505?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2010-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01207505?
The interventions under investigation include: Enhancing Emotion Regulation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01207505?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.